BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30273069)

  • 1. FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients.
    Turcott JG; Oñate-Ocaña LF; Soca-Chafre G; Ramírez-Tirado LA; Flores-Estrada D; Zatarain-Barrón ZL; Arrieta O
    Nutr Cancer; 2019; 71(3):409-417. PubMed ID: 30273069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
    LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
    Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
    Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
    Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.
    Blauwhoff-Buskermolen S; Ruijgrok C; Ostelo RW; de Vet HCW; Verheul HMW; de van der Schueren MAE; Langius JAE
    Support Care Cancer; 2016 Feb; 24(2):661-666. PubMed ID: 26160463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.
    Arrieta O; Luvián-Morales J; Turcott JG; Oñate-Ocaña LF
    Qual Life Res; 2018 Oct; 27(10):2709-2718. PubMed ID: 29987501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Anorexia and Cachexia: Screening in an Ambulatory Infusion Service and Nutrition Consultation
.
    Berry DL; Blonquist T; Nayak MM; Roper K; Hilton N; Lombard H; Hester A; Chiavacci A; Meyers S; McManus K
    Clin J Oncol Nurs; 2018 Feb; 22(1):63-68. PubMed ID: 29350696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorexia/cachexia-related quality of life for children with cancer.
    Lai JS; Cella D; Peterman A; Barocas J; Goldman S
    Cancer; 2005 Oct; 104(7):1531-9. PubMed ID: 16088963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine as Appetite Stimulant in Patients With Non-Small Cell Lung Cancer and Anorexia: A Randomized Clinical Trial.
    Arrieta O; Cárdenas-Fernández D; Rodriguez-Mayoral O; Gutierrez-Torres S; Castañares D; Flores-Estrada D; Reyes E; López D; Barragán P; Soberanis Pina P; Cardona AF; Turcott JG
    JAMA Oncol; 2024 Mar; 10(3):305-314. PubMed ID: 38206631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.
    Zhou T; Yang K; Thapa S; Fu Q; Jiang Y; Yu S
    Support Care Cancer; 2017 Apr; 25(4):1183-1189. PubMed ID: 27900546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
    Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
    Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
    Chang VT; Xia Q; Kasimis B
    J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
    Abraham M; Kordatou Z; Barriuso J; Lamarca A; Weaver JMJ; Cipriano C; Papaxoinis G; Backen A; Mansoor W
    PLoS One; 2019; 14(11):e0224540. PubMed ID: 31774822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
    LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
    J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.
    Zang YS; Fang Z; Li B
    Am J Hosp Palliat Care; 2013 Mar; 30(2):210-3. PubMed ID: 23393267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the functional assessment of anorexia/cachexia therapy instrument to assess quality of life in maintenance hemodialysis patients with cachexia.
    Yang Z; Luo Y; Lu H; Zou B; Wang H; Chen G; Wu Y; Huang Y
    Semin Dial; 2022 Jul; 35(4):330-336. PubMed ID: 35032061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
    Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
    Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
    Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
    Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer anorexia - cachexia syndrome.
    Muliawati Y; Haroen H; Rotty LW
    Acta Med Indones; 2012 Apr; 44(2):154-62. PubMed ID: 22745148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
    Zhang H; Garcia JM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.